Is BDX Worth Buying in 2026?

Becton, Dickinson and Co.

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-04-19

Here’s whether Becton, Dickinson and Co. (BDX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 61 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-5.42% over 10 days); weak 1-year return of -20.9%; 3-month momentum negative (-23.4%). Currently 25.6% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

BDX is trading below its 200-day MA ($184.80) — a key warning sign the longer-term trend is under pressure. An RSI of 61.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -20.9% compares to +35.1% for SPY (trailed the market by 56.0%). The current 25.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,911 today
vs. S&P 500 (SPY) — same period trailed market by 56.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($184.80)
Above 50-day MA ($167.65)
RSI(14) neutral zone (30–70) — currently 61.4
Positive return (-20.9%)
!Within 10% of period high (−25.6%)
Period Range $158.54
$152.79 $213.08
RSI (14) 61.4
0 · OversoldOverbought · 100

Key Metrics

Price$158.54
Period Return-20.9%
Period High$213.08
Period Low$152.79
Drawdown−25.6%
MA-50$167.65
MA-200$184.80
RSI (14)61.4
Avg Volume (30d)2.6M
vs. SPYtrailed by 56.0%
Return Rank#818 of 996

Trade BDX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers